Squarepoint
VNRX icon

Squarepoint’s VolitionRx Ltd VNRX Stock Holding History

Squarepoint’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Buy
+10,685
New +$25.8K ﹤0.01% 4317
2026
Q1 		– Sell
-6,733
Closed -$34.4K – 5037
2025
Q4 		$34.4K Buy
+6,733
New +$51.1K ﹤0.01% 4147
2025
Q3 		– Sell
-2,910
Closed -$44.2K – 5055
2025
Q2 		$44.2K Sell
2,910
-130
-4% -$1.43K ﹤0.01% 4322
2025
Q1 		$34.7K Buy
+3,040
New +$36.2K ﹤0.01% 4397
2020
Q3 		– Sell
-1,271
Closed -$99K – 2865
2020
Q2 		$99K Buy
+1,271
New +$91.8K ﹤0.01% 2018

Other funds holding VNRX

LIM
Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Squarepoint's VNRX Position: Q2 2026 in Review

Squarepoint opened a new position in VolitionRx Ltd (VNRX) in Q2 2026: 10,685 shares worth $14.4K. The stake represents ﹤0.01% of the portfolio and ranks #4317 among its holdings. This is a return to the name: Squarepoint previously reported a position in VNRX as recently as Q4 2025.

Squarepoint first reported a position in VNRX in Q2 2020 and has held it in 5 quarters since. The position peaked at $99K in Q2 2020. 24 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Squarepoint held 10,685 shares of VolitionRx Ltd worth $14.4K as of Q2 2026.
  • VolitionRx Ltd was a new Squarepoint position in Q2 2026.
  • VolitionRx Ltd made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4317 holding.
  • Squarepoint first reported a position in VolitionRx Ltd in Q2 2020 and has held it in 5 quarters since.
  • Squarepoint's VolitionRx Ltd position peaked at $99K in Q2 2020.
  • 24 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.